通过调节ROS,NOX4通过增加ferroptosis敏感性来调节胃癌细胞的入侵和扩散
1Department of Emergency Medicine, the Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou 310052, China.
International immunopharmacology
|April 9, 2024
概括
在胃癌 (GC) 中NOX4表达升高预示着预后不佳,并促进瘤的攻击性. 向NOX4可能会增强用于GC治疗的诱导铁亡的治疗方法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 胃癌 (GC) 仍然是一个重大的全球健康挑战.
- 了解推动GC进展的新型分子机制对于开发有效疗法至关重要.
- 反应性氧物种 (ROS) 和铁亡与癌症的发展有关.
研究的目的:
- 研究NOX4表达在胃癌中的作用.
- 为了确定NOX4在GC中的预后意义.
- 阐明NOX4影响GC进展的机制,特别是与ROS产生和铁亡的关系.
主要方法:
- 免疫组织化学被用来评估GC组织中的NOX4表达.
- 分析了TCGA和临床数据,以将NOX4表达与临床病理特征和患者存活率相关联.
- 实验涉及操纵GC细胞中的NOX4水平,以评估对侵入性,增殖,ROS产生和对ferroptosis诱导物的敏感性的影响.
主要成果:
- 与正常的邻近组织相比,GC组织中的NOX4表达显著上调.
- 较高的NOX4水平与总体存活率降低和瘤侵略性增加相关,将NOX4确定为预后不佳的独立预测因子.
- NOX4过度表达增强了ROS的产生,而NOX4抑制或抗氧化治疗减少了GC细胞的入侵和增殖.
- 过度表达NOX4的细胞对ferroptosis诱导物的敏感性增加,这表明在抑制GC进展方面发挥了协同作用.
结论:
- 通过增加ROS的产生,NOX4在促进胃癌的进展方面发挥着关键作用.
- 在GC中,NOX4是潜在的治疗点.
- 调节NOX4表达可以增强ferroptosis诱导剂的疗效,为胃癌提供了一个有前途的治疗策略.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.1K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
Necrosis
4.5K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


